Skip to main content

Patients’ social media use can threaten the reliability of clinical trials


Testing new pharmaceutical treatments is a complicated process. Very often, participants have preferences or hopes, either about what the test should measure or about what the outcome should be. Patients often enrol in the trial seeking access to experimental drugs while physicians usually have guesses about which treatment will work better. The sponsor will only recover millions of investment in the drug development if the trial is successful. Making sure that all these preferences do not shape the outcome of the test is crucial for its credibility. For that reason, treatments are often masked –“blinded” – so that neither physicians…

This story continues at The Next Web

from The Next Web http://bit.ly/2KDoJKa
Labels:

Comments

Post a Comment

Popular posts from this blog

TNW Podcast: Boris comes over to co-host; Slack’s Cal Henderson talks European tech

 Welcome to the new episode of the TNW Podcast — the show where we discuss the latest developments in the European technology ecosystem and feature interviews with some of the most interesting people in the industry. In today’s episode, Andrii is joined by Boris Veldhuijzen van Zanten, co-founder, member of the board, and former CEO of TNW. The topics discussed include the jobs created by Dutch startups, giant state funding for energy projects, translations of the word ‘computer’, and a bunch of other things in between. In the interview section, we’re featuring a conversation with Cal Henderson, co-founder and… This story continues at The Next Web from The Next Web https://ift.tt/jUgcNFD
Post a Comment
Read more

The TickTime is a clever productivity gadget that just works

With so much of the world’s workforce shifting to remote labor, a whole lot of people are trying to figure out how to be productive at home for the first time. Well, I’ve been working from home for years, and I still haven’t totally figured out the puzzle. There are no shortage of apps designed to help you be more productive, but I’m not sure anything I’ve tried has had as much potential as a little gadget called the TickTime. The concept is simple but clever. If you’ve ever heard of the Pomodoro method, which asks you to work in… This story continues at The Next Web from The Next Web https://ift.tt/2ySFso4
Post a Comment
Read more

Hands-on: Aventon’s new Pace ebikes are sleek rides that won’t break the bank

Aventon is one of the most popular ebike companies in the US, and its Pace cruiser bikes have long been the company’s best-selling rides. Now the company is updating its Pace 350 and 500, both of which received major redesigns this week meant to make the bikes more comfortable and easier to use. I was able to spend a few days with the latest version of the Pace 500 Step-Through, and it gets a whole lot right for not a lot of money. First, some basic specs. Here are the numbers for the Pace 350: Price: $1,399 Motor: 36V, 350W Battery:… This story continues at The Next Web from The Next Web https://ift.tt/lPIx85u
Post a Comment
Read more